EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL
<em>The activity of hyoscine butylbromide (buscopan) was evaluated in a placebobcontrolled trial, on pediatric patients with algid type of irritable bowel syndrome. Hyoscine butylbromide favored to the increase of quality of life in pediatric patients, alleviation of clinical symptoms of disea...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-01-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/1366 |
id |
doaj-c9bbb98c65414dcaa057ed8affb79750 |
---|---|
record_format |
Article |
spelling |
doaj-c9bbb98c65414dcaa057ed8affb797502020-11-24T21:01:33Zeng"Paediatrician" Publishers LLC Voprosy Sovremennoj Pediatrii1682-55271682-55352008-01-017236391366EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIALK.V. Arifullina0Novosibirsk State Medical University<em>The activity of hyoscine butylbromide (buscopan) was evaluated in a placebobcontrolled trial, on pediatric patients with algid type of irritable bowel syndrome. Hyoscine butylbromide favored to the increase of quality of life in pediatric patients, alleviation of clinical symptoms of disease, reliable decrease of malonic dialdehyde and increase of antioxidant activity of blood plasma significantly superior to placebo. Clinical efficacy of hyoscine butylbromide accompanies to its good tolerance and safety.</em><br /><strong><em>Key words: children, irritable bowel syndrome, hyoscine butylbromide, placebo controlled trial.</em></strong>http://vsp.spr-journal.ru:80/jour/article/view/1366 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
K.V. Arifullina |
spellingShingle |
K.V. Arifullina EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL Voprosy Sovremennoj Pediatrii |
author_facet |
K.V. Arifullina |
author_sort |
K.V. Arifullina |
title |
EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL |
title_short |
EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL |
title_full |
EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL |
title_fullStr |
EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL |
title_full_unstemmed |
EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL |
title_sort |
efficacy of hyoscine butylbromide in treatment of irritable bowel syndrome in children: placebo-controlled trial |
publisher |
"Paediatrician" Publishers LLC |
series |
Voprosy Sovremennoj Pediatrii |
issn |
1682-5527 1682-5535 |
publishDate |
2008-01-01 |
description |
<em>The activity of hyoscine butylbromide (buscopan) was evaluated in a placebobcontrolled trial, on pediatric patients with algid type of irritable bowel syndrome. Hyoscine butylbromide favored to the increase of quality of life in pediatric patients, alleviation of clinical symptoms of disease, reliable decrease of malonic dialdehyde and increase of antioxidant activity of blood plasma significantly superior to placebo. Clinical efficacy of hyoscine butylbromide accompanies to its good tolerance and safety.</em><br /><strong><em>Key words: children, irritable bowel syndrome, hyoscine butylbromide, placebo controlled trial.</em></strong> |
url |
http://vsp.spr-journal.ru:80/jour/article/view/1366 |
work_keys_str_mv |
AT kvarifullina efficacyofhyoscinebutylbromideintreatmentofirritablebowelsyndromeinchildrenplacebocontrolledtrial |
_version_ |
1716777647143387136 |